MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
Abstract Background MNAT1 (menage a trois 1, MAT1), a cyclin-dependent kinase-activating kinase (CAK) complex, highly expressed in diverse cancers and was involved in cancer molecular pathogenesis. However, its deliverance profile and biological function in osteosarcoma (OS) remain unclear. Methods...
Main Authors: | Chensheng Qiu, Weiliang Su, Nana Shen, Xiaoying Qi, Xiaolin Wu, Kai Wang, Lin Li, Zhu Guo, Hao Tao, Guanrong Wang, Bohua Chen, Hongfei Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-020-07687-3 |
Similar Items
-
MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance
by: Shan Zhou, et al.
Published: (2018-11-01) -
Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
by: Hong-Bo Li, et al.
Published: (2021-12-01) -
The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
by: Xue-jun Shao, et al.
Published: (2015-07-01) -
PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin
by: Zhenxing Si, et al.
Published: (2023-02-01) -
ITGB3 promotes cisplatin resistance in osteosarcoma tumors
by: Qian Li, et al.
Published: (2023-04-01)